<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>

<channel>
	<title>MATTO</title>
	<atom:link href="http://www.masstechtransfer.org/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.masstechtransfer.org</link>
	<description>Massachusetts Association of Technology Transfer Offices</description>
	<pubDate>Tue, 30 Apr 2013 13:23:18 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
	<language>en</language>
			<item>
		<title></title>
		<link>http://www.masstechtransfer.org/2013/01/30/753/</link>
		<comments>http://www.masstechtransfer.org/2013/01/30/753/#comments</comments>
		<pubDate>Wed, 30 Jan 2013 16:09:23 +0000</pubDate>
		<dc:creator>jgoldberg</dc:creator>
		
		<category><![CDATA[Events]]></category>

		<guid isPermaLink="false">http://www.masstechtransfer.org/?p=753</guid>
		<description><![CDATA[Dear MATTO members,
Please see news and events in the MATTO Matters newsletters: 
MATTO Seminar on May 15, 2013 at 3:30pm:  Licensing Know-how
Can a TTO license know-how, get rich and still retain its soul?  This MATTO seminar will show that the answer to all three questions is yes - well, maybe not rich, but [...]]]></description>
			<content:encoded><![CDATA[<p>Dear MATTO members,<br />
Please see news and events in the MATTO Matters newsletters: </p>
<p><strong>MATTO Seminar on May 15, 2013 at 3:30pm:  Licensing Know-how</strong><br />
Can a TTO license know-how, get rich and still retain its soul?  This MATTO seminar will show that the answer to all three questions is yes - well, maybe not rich, but richer.  Come and hear from four experienced practitioners - two from TTOs who have done know-how licenses recently and two transactional attorneys from WilmerHale who have done numerous know-how licenses. </p>
<p>The panel will discuss issues such as:  a) types of know-how that can be licensed, b) enforcing a know-how license, c) pure and mixed (with patent IP) know-how licenses, d) structuring royalties for know-how licenses, e) does an exclusive know-how license violate the open-dissemination-of-knowledge policies of academic institutions and the federal government.<br />
<strong>Panelists</strong>:  Jeff Johnson, WilmerHale; John Cosmopoulos, TuftsUniversity; and Irina Erenburg, Partners.<br />
 <strong>Moderator</strong>:  Belinda Juran - WilmerHale<br />
 <strong>Seminar Organizer</strong>: Robert Benson, Principal, South Shaker Associates</p>
<p><strong>The seminar is free but you have to <a href="https://events.r20.constantcontact.com/register/eventReg?oeidk=a07e7dgjyeja5d090ee&#038;oseq=&#038;c=&#038;ch=">register</a></strong></p>
<p><strong>Latest MATTO Matters newsletter:</strong><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112881635841.html">MATTO Matters March 14, 2013</p>
<p><strong> Please see <a href="http://media.umassp.edu/mattcenter/mattoseminars/Slides%20from%20MATTO%20seminar%20on%20SBIR%20STTR%20Funding%20of%20Academic%20Startups%20February%2013%202013.pdf">slides of Betsy Ohlsson-Wilhelm</a> from<strong>MATTO Seminar: </strong> <a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112224112371.html">SBIR Funding of Academic Startups on February 13, 2013 </a> </p>
<p><strong>Archived announcements:</strong><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112309209116.html">MATTO Matters February 20, 2013 </a><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112235466037.html">MATTO Matters January 29, 2013 </a><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112073352495.html">MATTO Matters January 10, 2013 </a><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1111468567366.html">MATTO Seminar:  MATTO Seminar November 6, 2012 -TTO actions for controling IP</a> </p>
]]></content:encoded>
			<wfw:commentRss>http://www.masstechtransfer.org/2013/01/30/753/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Children&#8217;s Hospital Boston: 3 positions</title>
		<link>http://www.masstechtransfer.org/2013/01/25/childrens-hospital-boston-3-positions/</link>
		<comments>http://www.masstechtransfer.org/2013/01/25/childrens-hospital-boston-3-positions/#comments</comments>
		<pubDate>Fri, 25 Jan 2013 17:25:50 +0000</pubDate>
		<dc:creator>jgoldberg</dc:creator>
		
		<category><![CDATA[Jobs]]></category>

		<guid isPermaLink="false">http://www.masstechtransfer.org/?p=744</guid>
		<description><![CDATA[Technology &#038; Innovation Development Office of the Children&#8217;s Hospital Boston is expanding and has openings for 3 new positions:
•	Licensing Associate: Entry level associate with advance degree in science and minimum of internship completion in licensing but experience preferred.
•	Strategic Initiatives and Business Development (SIBD): Will work with Associate Director of SIBD to establish collaborations with industry [...]]]></description>
			<content:encoded><![CDATA[<p>Technology &#038; Innovation Development Office of the Children&#8217;s Hospital Boston is expanding and has openings for 3 new positions:<br />
•	Licensing Associate: Entry level associate with advance degree in science and minimum of internship completion in licensing but experience preferred.<br />
•	Strategic Initiatives and Business Development (SIBD): Will work with Associate Director of SIBD to establish collaborations with industry across multiple sectors and work with Executive Director on hospital initiatives and new programs.  MBA or related business experience preferred.<br />
•	Clinical Research Contract Manager: Entry level contract associate in the Clinical Trials Office will deal with a variety of clinical research agreements and basic transactional agreements (CDAs, data sharing/use, etc).  No clinical research agreement experience necessary but JD or current law student preferred.<br />
For more information please contact Erik Halvorsen, TIDO Executive Director, at  <a href="erik.halvorsen@childrens.harvard.edu">erik.halvorsen@childrens.harvard.edu</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.masstechtransfer.org/2013/01/25/childrens-hospital-boston-3-positions/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Boston University: DIRECTOR, BUSINESS DEVELOPMENT, Office of Technology Development</title>
		<link>http://www.masstechtransfer.org/2013/01/25/boston-university-director-business-development-office-of-technology-development/</link>
		<comments>http://www.masstechtransfer.org/2013/01/25/boston-university-director-business-development-office-of-technology-development/#comments</comments>
		<pubDate>Fri, 25 Jan 2013 17:24:20 +0000</pubDate>
		<dc:creator>jgoldberg</dc:creator>
		
		<category><![CDATA[Jobs]]></category>

		<guid isPermaLink="false">http://www.masstechtransfer.org/?p=741</guid>
		<description><![CDATA[Boston University
DIRECTOR, BUSINESS DEVELOPMENT, Office of Technology Development 
Tracking Code
8142/L2012*
Job Description
Educate, encourage, and enable members of the Boston University community to transfer their discoveries/ideas into practical applications for public use. Manage the development of a portfolio of ideas in the Life Sciences sector through the commercialization process including patenting inventions, marketing to industry, and negotiating [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Boston University<br />
DIRECTOR, BUSINESS DEVELOPMENT, Office of Technology Development </strong><br />
Tracking Code<br />
8142/L2012*<br />
<strong>Job Description</strong><br />
Educate, encourage, and enable members of the Boston University community to transfer their discoveries/ideas into practical applications for public use. Manage the development of a portfolio of ideas in the Life Sciences sector through the commercialization process including patenting inventions, marketing to industry, and negotiating license agreements. Orchestrate the resources necessary to advance those ideas from inception to commercialization including facilitating consensus among internal stakeholders and external collaboration with CROs, venture development firms and pharmaceutical companies. Create and manage an external network of experts that can be called upon for support. Publicize discoveries from the BU Community through a variety of channels (websites, blogs, twitter, news articles, events, blast e- mails, targeted marketing, etc.)<br />
<strong>Required Skills </strong><br />
Requires: B.A./B.S. in the Life Sciences, graduate degree preferred, must be a self-starter that works well in teams, have strong networking skills and possess three to five years of relevant experience.<br />
<strong>Job Location </strong><br />
BOSTON, Massachusetts, United States<br />
<strong>Position Type</strong><br />
Full-Time/Regular<br />
<strong>Salary</strong><br />
Competitive<br />
<strong> To apply</strong> – visit <a href="https://bu.silkroad.com/epostings/index.cfm?fuseaction=app.jobinfo&#038;jobid=294510&#038;company_id=15509&#038;version=1&#038;source=ONLINE&#038;jobOwner=1016195&#038;aid=1">https://bu.silkroad.com/epostings/index.cfm?fuseaction=app.jobinfo&#038;jobid=294510&#038;company_id=15509&#038;version=1&#038;source=ONLINE&#038;jobOwner=1016195&#038;aid=1</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.masstechtransfer.org/2013/01/25/boston-university-director-business-development-office-of-technology-development/feed/</wfw:commentRss>
		</item>
		<item>
		<title></title>
		<link>http://www.masstechtransfer.org/2012/11/13/713/</link>
		<comments>http://www.masstechtransfer.org/2012/11/13/713/#comments</comments>
		<pubDate>Tue, 13 Nov 2012 20:37:17 +0000</pubDate>
		<dc:creator>jgoldberg</dc:creator>
		
		<category><![CDATA[Funding]]></category>

		<guid isPermaLink="false">http://www.masstechtransfer.org/2012/11/13/713/</guid>
		<description><![CDATA[Dear MATTO members,
Please see Funding Opportunities in the MATTO Matters newsletters:
Latest MATTO Matters newsletter:
MATTO Matters October 2012 
Archived announcements:
NCI&#8217;s SBIR program October 2, 2012 
]]></description>
			<content:encoded><![CDATA[<p>Dear MATTO members,<br />
Please see Funding Opportunities in the MATTO Matters newsletters:</p>
<p><strong>Latest MATTO Matters newsletter:</strong><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1111360415431.html">MATTO Matters October 2012 </a></p>
<p><strong>Archived announcements:</strong><br />
<a href="http://archive.constantcontact.com/fs095/1100584352356/archive/1111115321230.html">NCI&#8217;s SBIR program October 2, 2012 </a><br />
<a href=&#8221; 	http://archive.constantcontact.com/fs095/1100584352356/archive</p>
]]></content:encoded>
			<wfw:commentRss>http://www.masstechtransfer.org/2012/11/13/713/feed/</wfw:commentRss>
		</item>
		<item>
		<title></title>
		<link>http://www.masstechtransfer.org/2012/11/13/news-and-events/</link>
		<comments>http://www.masstechtransfer.org/2012/11/13/news-and-events/#comments</comments>
		<pubDate>Tue, 13 Nov 2012 20:09:50 +0000</pubDate>
		<dc:creator>jgoldberg</dc:creator>
		
		<category><![CDATA[News and Events]]></category>

		<guid isPermaLink="false">http://www.masstechtransfer.org/?p=684</guid>
		<description><![CDATA[Dear MATTO members,
Please see news and events in the MATTO Matters newsletters: 
MATTO Seminar on May 15, 2013 at 3:30pm:  Licensing Know-how
Can a TTO license know-how, get rich and still retain its soul?  This MATTO seminar will show that the answer to all three questions is yes - well, maybe not rich, but [...]]]></description>
			<content:encoded><![CDATA[<p>Dear MATTO members,<br />
Please see news and events in the MATTO Matters newsletters: </p>
<p><strong>MATTO Seminar on May 15, 2013 at 3:30pm:  Licensing Know-how</strong><br />
Can a TTO license know-how, get rich and still retain its soul?  This MATTO seminar will show that the answer to all three questions is yes - well, maybe not rich, but richer.  Come and hear from four experienced practitioners - two from TTOs who have done know-how licenses recently and two transactional attorneys from WilmerHale who have done numerous know-how licenses. </p>
<p>The panel will discuss issues such as:  a) types of know-how that can be licensed, b) enforcing a know-how license, c) pure and mixed (with patent IP) know-how licenses, d) structuring royalties for know-how licenses, e) does an exclusive know-how license violate the open-dissemination-of-knowledge policies of academic institutions and the federal government.<br />
<strong>Panelists</strong>:  Jeff Johnson, WilmerHale; John Cosmopoulos, TuftsUniversity; and Irina Erenburg, Partners.<br />
 <strong>Moderator</strong>:  Belinda Juran - WilmerHale<br />
 <strong>Seminar Organizer</strong>: Robert Benson, Principal, South Shaker Associates</p>
<p><strong>The seminar is free but you have to <a href="https://events.r20.constantcontact.com/register/eventReg?oeidk=a07e7dgjyeja5d090ee&#038;oseq=&#038;c=&#038;ch=">register</a></strong></p>
<p><strong>Latest MATTO Matters newsletter:</strong><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive<br />
<strong>Latest MATTO Matters newsletter:</strong><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112881635841.html">MATTO Matters March 14, 2013</p>
<p><strong> Please see <a href="http://media.umassp.edu/mattcenter/mattoseminars/Slides%20from%20MATTO%20seminar%20on%20SBIR%20STTR%20Funding%20of%20Academic%20Startups%20February%2013%202013.pdf">slides of Betsy Ohlsson-Wilhelm</a> from<strong>MATTO Seminar: </strong> <a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112224112371.html">SBIR Funding of Academic Startups on February 13, 2013 </a> </p>
<p><strong>Archived announcements:</strong><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112309209116.html">MATTO Matters February 20, 2013 </a><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112235466037.html">MATTO Matters January 29, 2013 </a><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1112073352495.html">MATTO Matters January 10, 2013 </a><br />
<a href="http://archive.constantcontact.com/fs150/1100584352356/archive/1111468567366.html">MATTO Seminar:  MATTO Seminar November 6, 2012 -TTO actions for controling IP</a> </p>
]]></content:encoded>
			<wfw:commentRss>http://www.masstechtransfer.org/2012/11/13/news-and-events/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Partners Healthcare / Massachusetts General Hospital</title>
		<link>http://www.masstechtransfer.org/2011/07/26/partners-healthcare-massachusetts-general-hospital/</link>
		<comments>http://www.masstechtransfer.org/2011/07/26/partners-healthcare-massachusetts-general-hospital/#comments</comments>
		<pubDate>Tue, 26 Jul 2011 21:45:34 +0000</pubDate>
		<dc:creator>mson</dc:creator>
		
		<category><![CDATA[Jobs]]></category>

		<guid isPermaLink="false">http://www.masstechtransfer.org/?p=599</guid>
		<description><![CDATA[Business Strategy and Licensing Manager
The office of Research, Ventures and Licensing (RVL) at Partners Healthcare is responsible for managing the interactions of the hospital community with industry. Research and Licensing, a division of RVL, is also responsible for the commercialization of intellectual property developed by hospital clinicians and research investigators and negotiates industry sponsored research [...]]]></description>
			<content:encoded><![CDATA[<p><em>Business Strategy and Licensing Manager</em></p>
<p>The office of Research, Ventures and Licensing (RVL) at Partners Healthcare is responsible for managing the interactions of the hospital community with industry. Research and Licensing, a division of RVL, is also responsible for the commercialization of intellectual property developed by hospital clinicians and research investigators and negotiates industry sponsored research agreements, material transfer agreements, and all other agreements related to intellectual property.</p>
<p>Reporting to an Associate Director or a Director, the Business Strategy and Licensing Manager will be responsible for managing intellectual property and related agreements for the Massachusetts General Hospital (MGH) community. More specifically, s/he will identify, evaluate, market and license technologies from a range of research disciplines.  Additional responsibilities include; identifying product opportunities and assessing the marketplace, and drafting and negotiating agreements pertaining to research, licensing and other aspects of investigator/industry interactions.</p>
<p><a href="http://www.masstechtransfer.org/files/2011/07/partners_20110726.doc">Position Details</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.masstechtransfer.org/2011/07/26/partners-healthcare-massachusetts-general-hospital/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Broad Institute</title>
		<link>http://www.masstechtransfer.org/2011/06/21/broad-institute/</link>
		<comments>http://www.masstechtransfer.org/2011/06/21/broad-institute/#comments</comments>
		<pubDate>Tue, 21 Jun 2011 19:00:14 +0000</pubDate>
		<dc:creator>mson</dc:creator>
		
		<category><![CDATA[Jobs]]></category>

		<guid isPermaLink="false">http://www.masstechtransfer.org/?p=595</guid>
		<description><![CDATA[Director, Industrial Collaborations and Technology Licensing
The Broad Institute stands on the leading edge of biomedical research, with a mission to broadly disseminate discoveries and information to the scientific community and general public. The Broad’s research is pursued through a blend of academic pursuits and industrial-scale lab production of biological, chemical and informational outputs, with scientists [...]]]></description>
			<content:encoded><![CDATA[<p><em>Director, Industrial Collaborations and Technology Licensing</em></p>
<p>The Broad Institute stands on the leading edge of biomedical research, with a mission to broadly disseminate discoveries and information to the scientific community and general public. The Broad’s research is pursued through a blend of academic pursuits and industrial-scale lab production of biological, chemical and informational outputs, with scientists working side-by-side from Broad, MIT, Harvard, and Harvard-affiliated hospitals. The Director plays a key role in navigating this rapidly evolving landscape to ensure that the Broad Institute’s intellectual property and technological developments are effectively managed to support the mission and the strategic interests of Broad and its partner institutions.</p>
<p><a href="http://www.masstechtransfer.org/files/2011/08/broad_20110621.doc">Position Details</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.masstechtransfer.org/2011/06/21/broad-institute/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Millipore Corporation</title>
		<link>http://www.masstechtransfer.org/2010/06/21/millipore-corporation/</link>
		<comments>http://www.masstechtransfer.org/2010/06/21/millipore-corporation/#comments</comments>
		<pubDate>Mon, 21 Jun 2010 16:13:42 +0000</pubDate>
		<dc:creator>mson</dc:creator>
		
		<category><![CDATA[Jobs]]></category>

		<guid isPermaLink="false">http://www.masstechtransfer.org/?p=520</guid>
		<description><![CDATA[Business Development Manager
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools and services for bioscience research and biopharmaceutical manufacturing. Since its founding in 1954, Millipore has expanded its capabilities through strategic acquisitions, targeted capital investments, and organic growth.
Today we offer an extensive portfolio of products and services in: Life Sciences, Drug Discovery [...]]]></description>
			<content:encoded><![CDATA[<p><em>Business Development Manager</em></p>
<p>Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools and services for bioscience research and biopharmaceutical manufacturing. Since its founding in 1954, Millipore has expanded its capabilities through strategic acquisitions, targeted capital investments, and organic growth.</p>
<p>Today we offer an extensive portfolio of products and services in: Life Sciences, Drug Discovery and Development, Lab Filtration, Lab Water, Upstream Bioprocessing, Downstream Bioprocessing and Process Monitoring.  Our global customers include private research institutions,  analytical, academic and clinical laboratories and biotech, pharmaceutical and contract manufacturing organizations.</p>
<p>There is an opening for a Business Development Manager in our Bedford, MA office.  The successful candidate will be part of the Expression Technologies group within the marketing department of the Upstream Processing business unit in Millipore’s Bioprocess Division.</p>
<p><a href="http://www.masstechtransfer.org/files/2010/06/millipore_20100618.doc">Position Details</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.masstechtransfer.org/2010/06/21/millipore-corporation/feed/</wfw:commentRss>
		</item>
		<item>
		<title>US-India BioPharma Summit</title>
		<link>http://www.masstechtransfer.org/2008/06/09/us-india-biopharma-summit-2/</link>
		<comments>http://www.masstechtransfer.org/2008/06/09/us-india-biopharma-summit-2/#comments</comments>
		<pubDate>Mon, 09 Jun 2008 16:38:42 +0000</pubDate>
		<dc:creator>mson</dc:creator>
		
		<category><![CDATA[Links]]></category>

		<guid isPermaLink="false">http://www.masstechtransfer.org/2008/06/09/us-india-biopharma-summit-2/</guid>
		<description><![CDATA[Delivering Affordable Innovation through Cross Border Partnerships
Location: President&#8217;s Ballroom, Hyatt Regency, Cambridge, Massachusetts
The Summit discussions cover:

 Drug Discovery, Development, Clinical Trials, In/Out Licensing, IP and Regulatory Issues
Funding Innovation, Cross Border Investments, Investment Opportunities and M&#38;A trends in the US- India Bio Pharma industry

Summit open only to Senior Biotech/Pharma/Medical Devices/Healthcare executives, Venture Capitalists, Investment Bankers, Policy [...]]]></description>
			<content:encoded><![CDATA[<p>Delivering Affordable Innovation through Cross Border Partnerships<br />
Location: President&#8217;s Ballroom, Hyatt Regency, Cambridge, Massachusetts</p>
<p>The Summit discussions cover:</p>
<ul>
<li> Drug Discovery, Development, Clinical Trials, In/Out Licensing, IP and Regulatory Issues</li>
<li>Funding Innovation, Cross Border Investments, Investment Opportunities and M&amp;A trends in the US- India Bio Pharma industry</li>
</ul>
<p>Summit open only to Senior Biotech/Pharma/Medical Devices/Healthcare executives, Venture Capitalists, Investment Bankers, Policy Makers and Academia.</p>
<p>For more information and register please visit <a href="http://www.usaindiachamber.org" title="http://www.usaindiachamber.org" target="_blank">www.usaindiachamber.org</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.masstechtransfer.org/2008/06/09/us-india-biopharma-summit-2/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
